Stay updated with breaking news from Target Labs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Regulatory News: Mauna Kea Technologies (Euronext: MKEA) (Paris:MKEA) (OTCQX:MKEAY), inventor of Cellvizio, the multi-disciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform
Confocal laser endomicroscopy is an imaging technology that delivers visibility into cellular activity that enables physicians to assess areas of concern in cases where conventional disease screening returns ambiguous results.
Following its 2021 restructuring, Company experiences stable U.S sales growth, including improved gross margin and anticipated reductions in operating losses Webinar april 21st 2022 at 7:00 pm https://us02web.zoom.us/webinar/register/WN_KuWBx3iYSMyew6PkI3LfeA Regulatory